Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesEfficacy of High Doses of Daptomycin versus Alternative Therapies against Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureus
Antimicrobial Agents and Chemotherapy, 10/06/09
Murillo O et al. – Daptomycin at high doses proved to be as effective as rifampin, and the two were the most active therapies for this experimental foreign–body infection. These high doses ensured a profile of safety from the development of resistance.
Related Articles
Scapular Abscess, Septic Emboli, and Deep Vein Thrombosis in a Healthy Child Due to Community-Acquired Methicillin-Resistant Staphylococcus aureus: Case Report
Pediatric Emergency Care, 10/29/09
Relevance Score: 69%
Staphylococcus aureus nasal carriage and its contributing factors
Future Microbiology, 11/05/09
Relevance Score: 68%
SpectraTM MRSA, A New Chromogenic Agar Medium to Screen for Methicillin-Resistant Staphylococcus aureus
Journal of Clinical Microbiology, 11/13/09
Relevance Score: 67%
Surmounting antimicrobial resistance in the Millennium Superbug: Staphylococcus aureus
Central European Journal of Medicine, 10/30/09
Relevance Score: 67%
Efficacy of a swab transport system in maintaining long-term viability of Staphylococcus aureus
Diagnostic Microbiology and Infectious Disease, 10/22/09
Relevance Score: 67%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Infections after the use of alemtuzumab in solid organ transplant recipients: a comparative study
Diagnostic Microbiology and Infectious Disease, 12/09/09
Screening of some Tanzanian medicinal plants for their trypanocidal and cytotoxic activities
Phytotherapy Research, 12/09/09
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial
The Lancet - Early Online Publication, 12/09/09
Sponsor
Article Search
Sponsor